Drug Abuse, Mental Illness and Co-Occurring Disorders Video
Drug Abuse, Mental Illness And Co-Occurring Disorders Video – Drug Use and Mental Health; Target Audience Statement: Primary target audiences for this program will include law enforcement officials, drug prevention specialists, Drug-Free Communities Act grantees, administrators, school drug counselors, treatment providers, drug court members, policy makers, business leaders, coalition volunteers, drug demand reduction coordinators, criminal justice professionals, members of the religious community and other community partners who may be interested. This program is also suitable for Public Access television distribution. Program Summary And Objectives: “Millions of American today receive health care for mental or substance-use problems and illnesses. These conditions are the leading cause of combined disability and death of women and the second highest of men.” “Improving the Quality of health Care for Mental and Substance-Use Conditions,” Institute of Medicine Report, November 1, 2005; Studies are showing an alarming trend, incidents of mental illness related to drug use are on the rise. It’s unclear what came first, did a predisposition to mental illness lead to drug use, or is it the other way around? No matter what, co-occurring disorders are a problem. Especially in the wake of this year’s hurricanes and other disasters, mental health and substance abuse professionals need to be poised to provide additional care for those suffering serious mental trauma and who may turn to alcohol and drugs as a result. During this hour-long …
Drug Shortages Persist in US, Harming Care
Filed under: drug addiction treatment act
The Food and Drug Administration said that shortages of six drugs — medicines used during surgery and to treat conditions like congestive heart failure — could get worse after a big compounding pharmacy closed over concerns about drug safety. … A …
Read more on New York Times
New Orphan Drug Approved for Mesothelioma
Filed under: drug addiction treatment act
The Orphan Drug Act allows the FDA to designate a drug as an orphan drug if it is used to treat fewer than 200,000 people in the U.S. Any illness that affects fewer than 200,000 people is considered a rare disease. Mesothelioma is one of the rarest of …
Read more on Surviving Mesothelioma